- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.73 Å
- Oligo State
- monomer
- Ligands
- 2 x NAA- NAA: 2-acetamido-2-deoxy-beta-D-allopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-allopyranose(Non-covalent)
- 25 x GOL: GLYCEROL(Non-functional Binders)
GOL.3: 8 residues within 4Å:- Chain A: K.394, Y.422, Y.428, D.429, D.430, S.431
- Ligands: ACT.25, ACT.39
Ligand excluded by PLIPGOL.4: 7 residues within 4Å:- Chain A: T.4, R.5, T.46, H.47, R.90, Y.209
- Ligands: GOL.23
Ligand excluded by PLIPGOL.5: 3 residues within 4Å:- Chain A: Q.160, R.163, T.164
Ligand excluded by PLIPGOL.6: 6 residues within 4Å:- Chain A: R.163, A.205, P.206, L.207, D.208, K.285
Ligand excluded by PLIPGOL.7: 6 residues within 4Å:- Chain A: P.261, F.264, S.265, R.440, Y.441, T.442
Ligand excluded by PLIPGOL.8: 5 residues within 4Å:- Chain A: R.245, T.257, F.260, P.261, S.262
Ligand excluded by PLIPGOL.9: 7 residues within 4Å:- Chain A: Y.324, L.326, V.327, G.328, C.329, D.330, V.333
Ligand excluded by PLIPGOL.10: 4 residues within 4Å:- Chain A: F.191, F.192, R.195
- Ligands: GOL.13
Ligand excluded by PLIPGOL.11: 10 residues within 4Å:- Chain A: E.255, R.258, V.444, G.445, P.446, L.449, L.494, K.495, V.496
- Ligands: ACT.48
Ligand excluded by PLIPGOL.12: 5 residues within 4Å:- Chain A: N.77, K.133, D.134, Y.135, G.136
Ligand excluded by PLIPGOL.13: 5 residues within 4Å:- Chain A: Q.148, A.149, S.194, R.195
- Ligands: GOL.10
Ligand excluded by PLIPGOL.15: 4 residues within 4Å:- Chain A: W.360, N.361, D.362, K.363
Ligand excluded by PLIPGOL.16: 6 residues within 4Å:- Chain A: F.232, Y.392, Q.395, Q.396, M.435, R.440
Ligand excluded by PLIPGOL.18: 2 residues within 4Å:- Chain A: E.222, F.240
Ligand excluded by PLIPGOL.19: 5 residues within 4Å:- Chain A: S.198, L.249, W.251, M.278
- Ligands: ACT.26
Ligand excluded by PLIPGOL.20: 4 residues within 4Å:- Chain A: A.464, Q.465, G.481, Y.482
Ligand excluded by PLIPGOL.21: 6 residues within 4Å:- Chain A: Y.343, E.347, L.350, R.358, Y.380, D.382
Ligand excluded by PLIPGOL.22: 5 residues within 4Å:- Chain A: R.358, W.360, E.384, Y.388
- Ligands: ACT.29
Ligand excluded by PLIPGOL.23: 5 residues within 4Å:- Chain A: R.90, A.177, P.179, Q.181
- Ligands: GOL.4
Ligand excluded by PLIPGOL.31: 3 residues within 4Å:- Chain A: N.36, K.41, R.411
Ligand excluded by PLIPGOL.32: 5 residues within 4Å:- Chain A: R.5, K.43, D.420, N.424
- Ligands: ACT.46
Ligand excluded by PLIPGOL.42: 4 residues within 4Å:- Chain A: I.224, Y.308, S.309, S.310
Ligand excluded by PLIPGOL.44: 7 residues within 4Å:- Chain A: D.54, D.64, P.65, Y.100, V.106, S.107
- Ligands: ACT.45
Ligand excluded by PLIPGOL.54: 5 residues within 4Å:- Chain A: G.250, W.251, S.252, E.255
- Ligands: ACT.48
Ligand excluded by PLIPGOL.57: 2 residues within 4Å:- Chain A: D.323, W.325
Ligand excluded by PLIP- 4 x PO4: PHOSPHATE ION(Non-functional Binders)
PO4.14: 3 residues within 4Å:- Chain A: K.43, A.84, H.85
2 PLIP interactions:2 interactions with chain A- Salt bridges: A:K.43, A:H.85
PO4.17: 3 residues within 4Å:- Chain A: K.387, R.421, Y.428
3 PLIP interactions:3 interactions with chain A- Water bridges: A:K.387
- Salt bridges: A:K.387, A:R.421
PO4.55: 2 residues within 4Å:- Chain A: E.24, R.78
7 PLIP interactions:7 interactions with chain A- Hydrogen bonds: A:E.24
- Water bridges: A:E.24, A:D.74, A:R.78, A:R.78, A:R.78
- Salt bridges: A:R.78
PO4.56: 4 residues within 4Å:- Chain A: K.199, N.248
- Ligands: ACT.26, ACT.59
5 PLIP interactions:5 interactions with chain A- Hydrogen bonds: A:N.248
- Water bridges: A:D.153, A:K.199, A:N.248
- Salt bridges: A:K.199
- 27 x ACT: ACETATE ION(Non-functional Binders)
ACT.24: 2 residues within 4Å:- Chain A: R.258, T.442
Ligand excluded by PLIPACT.25: 5 residues within 4Å:- Chain A: F.423, N.424, A.425, A.426
- Ligands: GOL.3
Ligand excluded by PLIPACT.26: 4 residues within 4Å:- Chain A: N.248, L.249
- Ligands: GOL.19, PO4.56
Ligand excluded by PLIPACT.29: 4 residues within 4Å:- Chain A: E.384, K.387, L.433
- Ligands: GOL.22
Ligand excluded by PLIPACT.30: 4 residues within 4Å:- Chain A: D.330, E.331, R.334
- Ligands: ACT.34
Ligand excluded by PLIPACT.33: 4 residues within 4Å:- Chain A: G.302, G.303, Y.370, A.372
Ligand excluded by PLIPACT.34: 5 residues within 4Å:- Chain A: D.330, E.331, Q.345, Q.348
- Ligands: ACT.30
Ligand excluded by PLIPACT.35: 6 residues within 4Å:- Chain A: K.391, Q.395, S.431, L.433
- Ligands: ACT.36, ACT.52
Ligand excluded by PLIPACT.36: 4 residues within 4Å:- Chain A: S.431, Q.432, D.434
- Ligands: ACT.35
Ligand excluded by PLIPACT.37: 1 residues within 4Å:- Chain A: T.437
Ligand excluded by PLIPACT.38: 5 residues within 4Å:- Chain A: G.105, V.106, S.107, H.108, A.109
Ligand excluded by PLIPACT.39: 7 residues within 4Å:- Chain A: K.391, K.394, Q.395, D.430, S.431
- Ligands: GOL.3, ACT.52
Ligand excluded by PLIPACT.40: 5 residues within 4Å:- Chain A: Y.319, N.321, A.322, Y.324, K.336
Ligand excluded by PLIPACT.41: 3 residues within 4Å:- Chain A: F.191, E.222
- Ligands: ACT.53
Ligand excluded by PLIPACT.43: 2 residues within 4Å:- Chain A: P.282, S.283
Ligand excluded by PLIPACT.45: 4 residues within 4Å:- Chain A: T.16, D.64, Y.100
- Ligands: GOL.44
Ligand excluded by PLIPACT.46: 4 residues within 4Å:- Chain A: D.420, N.424, A.425
- Ligands: GOL.32
Ligand excluded by PLIPACT.47: 2 residues within 4Å:- Chain A: D.74, N.77
Ligand excluded by PLIPACT.48: 5 residues within 4Å:- Chain A: W.251, E.255, P.446
- Ligands: GOL.11, GOL.54
Ligand excluded by PLIPACT.49: 1 residues within 4Å:- Chain A: A.322
Ligand excluded by PLIPACT.50: 2 residues within 4Å:- Chain A: E.279, G.280
Ligand excluded by PLIPACT.51: 1 residues within 4Å:- Chain A: N.353
Ligand excluded by PLIPACT.52: 3 residues within 4Å:- Chain A: Q.395
- Ligands: ACT.35, ACT.39
Ligand excluded by PLIPACT.53: 9 residues within 4Å:- Chain A: D.216, L.217, A.218, W.221, E.222, F.240, L.266
- Ligands: AMI.28, ACT.41
Ligand excluded by PLIPACT.58: 0 residues within 4Å:- (No contacts)
Ligand excluded by PLIPACT.59: 4 residues within 4Å:- Chain A: A.149, S.198, N.248
- Ligands: PO4.56
Ligand excluded by PLIPACT.60: 0 residues within 4Å:- (No contacts)
Ligand excluded by PLIP- 2 x AMI: ALLOSAMIZOLINE(Non-covalent)
AMI.27: 14 residues within 4Å:- Chain A: Y.11, F.52, G.97, W.98, D.143, E.145, A.185, M.213, Y.215, D.216, Y.293, M.402, W.404
- Ligands: NAA-NAA.1
4 PLIP interactions:4 interactions with chain A- Hydrophobic interactions: A:W.404
- Hydrogen bonds: A:W.98, A:Y.215, A:D.216
AMI.28: 14 residues within 4Å:- Chain A: Y.146, A.187, G.188, G.189, A.190, F.191, F.192, M.213, Y.215, D.216, L.217, W.221
- Ligands: NAA-NAA.2, ACT.53
4 PLIP interactions:4 interactions with chain A- Hydrophobic interactions: A:F.192
- Hydrogen bonds: A:G.188, A:G.189, A:M.213
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Ebi, S. et al., X-ray Crystal structure of glycoside hydrolase family 18 chitinase from Serratia marcescens hexahistigine-tagged SmChiB with allosamidin. To Be Published
- Release Date
- 2025-04-02
- Peptides
- Chitinase B: A
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
A
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.73 Å
- Oligo State
- monomer
- Ligands
- 2 x NAA- NAA: 2-acetamido-2-deoxy-beta-D-allopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-allopyranose(Non-covalent)
- 25 x GOL: GLYCEROL(Non-functional Binders)
- 4 x PO4: PHOSPHATE ION(Non-functional Binders)
- 27 x ACT: ACETATE ION(Non-functional Binders)
- 2 x AMI: ALLOSAMIZOLINE(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Ebi, S. et al., X-ray Crystal structure of glycoside hydrolase family 18 chitinase from Serratia marcescens hexahistigine-tagged SmChiB with allosamidin. To Be Published
- Release Date
- 2025-04-02
- Peptides
- Chitinase B: A
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
A